- Home
- PCRX vs OPK Comparison
PCRX vs OPK Comparison
Compare PCRX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- OPK
- Stock Information
- Founded
- PCRX 2006
- OPK 2007
- Country
- PCRX United States
- OPK United States
- Employees
- PCRX N/A
- OPK N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- PCRX Health Care
- OPK Health Care
- Exchange
- PCRX Nasdaq
- OPK Nasdaq
- Market Cap
- PCRX 1.2B
- OPK 1.0B
- IPO Year
- PCRX 2011
- OPK 1995
- Fundamental
- Price
- PCRX $25.16
- OPK $1.68
- Analyst Decision
- PCRX Buy
- OPK Strong Buy
- Analyst Count
- PCRX 9
- OPK 3
- Target Price
- PCRX $26.22
- OPK $2.75
- AVG Volume (30 Days)
- PCRX 805.4K
- OPK 2.8M
- Earning Date
- PCRX 02-27-2025
- OPK 02-27-2025
- Dividend Yield
- PCRX N/A
- OPK N/A
- EPS Growth
- PCRX N/A
- OPK N/A
- EPS
- PCRX N/A
- OPK N/A
- Revenue
- PCRX $694,957,000.00
- OPK $711,408,000.00
- Revenue This Year
- PCRX $5.55
- OPK N/A
- Revenue Next Year
- PCRX $5.64
- OPK $0.00
- P/E Ratio
- PCRX N/A
- OPK N/A
- Revenue Growth
- PCRX 4.40
- OPK N/A
- 52 Week Low
- PCRX $11.16
- OPK $0.86
- 52 Week High
- PCRX $31.67
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- PCRX 52.48
- OPK 62.47
- Support Level
- PCRX $25.41
- OPK $1.60
- Resistance Level
- PCRX $26.89
- OPK $1.68
- Average True Range (ATR)
- PCRX 1.18
- OPK 0.06
- MACD
- PCRX -0.36
- OPK 0.01
- Stochastic Oscillator
- PCRX 4.35
- OPK 77.78
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.